Cilta-cel or Standard Care in Lenalidomide-Refractory Multiple Myeloma

San-Miguel, J., Dhakal, B., Yong, K., Spencer, A., Anguille, S., Mateos, M. V., Fernández De Larrea, C., Martínez-López, J., Moreau, P., Touzeau, C., Leleu, X., Avivi, I., Cavo, M., Ishida, T., Kim, S. J., Roeloffzen, W., Van De Donk, N. W. C. J., Dytfeld, D., Sidana, S., Costa, L. J., & 23 othersOriol, A., Popat, R., Khan, A. M., Cohen, Y. C., Ho, P. J., Griffin, J., Lendvai, N., Lonardi, C., Slaughter, A., Schecter, J. M., Jackson, C. C., Connors, K., Li, K., Zudaire, E., Chen, D., Gilbert, J., Yeh, T. M., Nagle, S., Florendo, E., Pacaud, L., Patel, N., Harrison, S. J. & Einsele, H., 27-Jul-2023, In: New England Journal of Medicine. 389, 4, p. 335-347 13 p.

Research output: Contribution to journal › Article › Academic › peer-review

The management of light chain (AL) amyloidosis in Europe: clinical characteristics, treatment patterns, and efficacy outcomes between 2004 and 2018

Palladini, G., Schönland, S., Merlini, G., Milani, P., Jaccard, A., Bridoux, F., Dimopoulos, M. A., Ravichandran, S., Hegenbart, U., Roeloffzen, W., Cibeira, M. T., Agis, H., Minnema, M. C., Bergantim, R., Hájek, R., João, C., Leonidakis, A., Cheliotis, G., Sonneveld, P., Kastritis, E., & 1 othersWechalekar, A., 25-Jan-2023, (E-pub ahead of print) In: Blood cancer journal. 13, 8 p., 19.

Research output: Contribution to journal › Article › Academic › peer-review

Treatment of primary plasma cell leukaemia with carfilzomib and lenalidomide-based therapy (EMN12/HOVON-129): final analysis of a non-randomised, multicentre, phase 2 study

van de Donk, N. W. C. J., Minnema, M. C., van der Holt, B., Schjesvold, F., Wu, K. L., Broijl, A., Roeloffzen, W. W. H., Gadisseur, A., Pietrantuono, G., Pour, L., van der Velden, V. H. J., Lund, T., Offidani, M., Grasso, M., Giaccone, L., Razawy, W., Tacchetti, P., Mancuso, K., Silkjaer, T., Caers, J., & 8 othersZweegman, S., Hájek, R., Benjamin, R., Vangsted, A. J., Boccadoro, M., Gay, F., Sonneveld, P. & Musto, P., Oct-2023, In: The Lancet Oncology. 24, 10, p. 1119-1133 15 p.

Research output: Contribution to journal › Article › Academic › peer-review

Increased mortality risk in multiple-myeloma patients with subsequent malignancies: a population-based study in the Netherlands

Brink, M., Minnema, M. C., Visser, O., Levin, M-D., Posthuma, E. F. M. W., Broijl, A., Sonneveld, P., van der Klift, M., Roeloffzen, W. W. H., Westerman, M., van Rooijen, C. R., Geerts, P. A. F., Zweegman, S., van de Donk, N. W. C. J. & Dinmohamed, A. G., 15-Mar-2022, In: Blood cancer journal. 12, 3, 4 p., 41.

Research output: Contribution to journal › Letter › Academic › peer-review

LocoMMotion: a prospective, non-interventional, multinational study of real-life current standards of care in patients with relapsed and/or refractory multiple myeloma

Mateos, M-V., Weisel, K., De Stefano, V., Goldschmidt, H., Delforge, M., Mohty, M., Cavo, M., Vij, R., Lindsey-Hill, J., Dytfeld, D., Angelucci, E., Perrot, A., Benjamin, R., van de Donk, N. W. C. J., Ocio, E. M., Scheid, C., Gay, F., Roeloffzen, W., Rodriguez-Otero, P., Broijl, A., & 13 othersPotamianou, A., Sakabedoyan, C., Semerjian, M., Keim, S., Strulev, V., Schecter, J. M., Vogel, M., Wapenaar, R., Nesheiwat, T., San-Miguel, J., Sonneveld, P., Einsele, H. & Moreau, P., May-2022, In: Leukemia. 36, 5, p. 1371-1376 6 p.

Research output: Contribution to journal › Article › Academic › peer-review